Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and ...
Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...
Nxera Pharma Proposes Changes to its Board of Directors
Ms. Naoko Shimura and Ms. Nicola Rabson nominated for appointment as new External DirectorsMr. Shinichi Tamura, Mr. Tomohiro Tohyama and Mr.